While p300 is considered to serve as a tumor suppressor gene that prevents carcinogenesis in normal epithelial cells [7, 8], p300 has often been observed to be overexpressed in various types of cancer and p300 overexpression in such cancers has been associated with worse patient outcomes [9–16]. The gene discussed is EP300; the disease is cancer.